Especially upon early diagnosis of the presence of such genetic alterations, for example, using liquid biopsies that can detect PIK3CA mutation [150], it is tempting to speculate that administration of low doses of PI3K pathway inhibitors could be used as a strategy to prevent cancer development and/or progression [151]. Here, PIK3CD is linked to cancer.